Eam Global Investors LLC Mirum Pharmaceuticals, Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$18.42 - $27.5 $340,825 - $508,832	-18,503 Reduced 23.21%	61,233 $1.19 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $1.24 Million - $1.91 Million	79,736 New	79,736 $1.76 Million
Q2 2020 Aug 13, 2020	SELL	$11.51 - $20.97 $796,917 - $1.45 Million	-69,237 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$9.38 - $23.79 $81,868 - $207,639	8,728 Added 14.42%	69,237 $969,000
Q4 2019 Feb 10, 2020	BUY	$6.84 - $25.9 $413,881 - $1.57 Million	60,509 New	60,509 $1.48 Million

210

53.8M

2.6K

99.7K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.84B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.